Effects of endogenous dopamine on kinetics of [3H]N‐methylspiperone and [3H]raclopride binding in the rat brain
- 1 November 1991
- Vol. 9 (3), 188-194
- https://doi.org/10.1002/syn.890090305
Abstract
Competition by endogenous dopamine with the binding of D2 dopamine receptor ligands may be important in the interpretation of positron emission tomography (PET) neuroreceptor studies. PET studies with N‐methylspiperone (NMSP) have revealed increased D2 dopamine receptors in schizophrenia, whereas studies with raclopride (RAC) have not detected such differences. This may be due, at least in part, to differences in competition with endogenous dopamine for ligand binding. To determine effects of endogenous dopamine on in vivo receptor binding, adult male rats were preinjected with amphetamine and reserpine prior to [3H]NMSP or [3H]RAC. Striatal to cerebellar ratios of ligand binding were determined. To approximate the conditions of a PET study, a kinetic model was employed to examine effects of pharmacologically increasing brain dopamine levels (amphetamine pretreatment) on PET ligand binding. In these experiments, tail veins and arteries were cannulated and kinetic parameters determined from normalized integral plots in rats treated with amphetamine prior to radioligand injection. Both [3H]NMSP (43.5%) and [3H]RAC (41.5%) binding were significantly decreased after amphetamine pretreatment, whereas after reserpine pretreatment [3H]RAC binding was increased (52.7%). Kinetic studies revealed a marked resistance of [3]NMSP to competition with endogenous dopamine released by amphetamine. In contrast, kinetic parameters of [3H]RAC were markedly reduced at all time intervals. This suggests significant differences in competition with endogenous dopamine by [3H]NMSP and [3H]RAC, determined kinetically. These findings may have important implications for the interpretation of PET neuroreceptor studies.Keywords
This publication has 27 references indexed in Scilit:
- In vivo labelling of rat brain dopamine D-2 receptorsJournal of Neural Transmission, 1988
- Exogenous 1-dopa alters spiroperidol binding, invivo, in the mouse striatumLife Sciences, 1986
- Quantification of Neuroreceptors in the Living Human Brain. I. Irreversible Binding of LigandsJournal of Cerebral Blood Flow & Metabolism, 1986
- Quantification of Neuroreceptors in the Living Human Brain. II. Inhibition Studies of Receptor Density and AffinityJournal of Cerebral Blood Flow & Metabolism, 1986
- Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data. GeneralizationsJournal of Cerebral Blood Flow & Metabolism, 1985
- []-N-: The radioligand of choice for pett studies of the dopamine receptor in human brainLife Sciences, 1985
- Calculation of cerebral glucose phosphorylation from brain uptake of glucose analogs in vivo: A re-examinationBrain Research Reviews, 1982
- Invivo receptor binding: Attempts to improve specific/ non-specific ratiosLife Sciences, 1979
- The substituted benzamides - a novel class of dopamine antagonistsLife Sciences, 1979
- Excessive Increase in Oxygen Uptake and Blood Flow in the Brain during Amphetamine IntoxicationActa Physiologica Scandinavica, 1976